Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518882
Status:
COMPLETED
Last Update Posted:
2017-03-08
First Post:
2007-08-20
Brief Title:
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Organization Data
Organization:
Novo Nordisk AS
Class:
INDUSTRY
Study ID:
NN2211-1797
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novo Nordisk AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None